Dr Reddys Laboratories Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 10, 2026

Key Highlights

The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1271 as of 10 Jun 15:30 . The p/e ratio of Dr Reddys Laboratories Ltd changed from 38.5 to 16.9 over 5 quarters. This represents a CAGR of -48.25% The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00% The market cap of Dr Reddys Laboratories Ltd changed from ₹ 75095 crore to ₹ 95465 crore over 5 quarters. This represents a CAGR of 21.17% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The revenue of Dr Reddys Laboratories Ltd for the Mar '26 is ₹ 8026 crore as compare to the Dec '25 revenue of ₹ 9024 crore. This represent the decline of -11.06% The revenue of Sanofi India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Dr Reddys Laboratories Ltd for the Mar '26 is ₹ 862.5 crore as compare to the Dec '25 ebitda of ₹ 2158 crore. This represent the decline of -60.04% The ebitda of Sanofi India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Dr Reddys Laboratories Ltd changed from ₹ 1392 crore to ₹ 221.3 crore over 8 quarters. This represents a CAGR of -60.13% The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The dividend payout of Dr Reddys Laboratories Ltd changed from 19.03 % to 12.47 % over 5 quarters. This represents a CAGR of -28.69% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Dr Reddys Laboratories Ltd

Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's portfolio of products and services include Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
Dr. Reddy's operates in markets across the globe.
Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Dr Reddys Laboratories Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Dr Reddys Laboratories Ltd or Sanofi India Ltd?

Market cap of Dr Reddys Laboratories Ltd is 106,149 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Dr Reddys Laboratories Ltd and Sanofi India Ltd?

The stock performance of Dr Reddys Laboratories Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Reddys Laboratories Ltd and Sanofi India Ltd?

As of June 10, 2026, the Dr Reddys Laboratories Ltd stock price is INR ₹1271.75. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Dr Reddys Laboratories Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Dr Reddys Laboratories Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.